ZC3H12D
Basic information
Region (hg38): 6:149446794-149485014
Previous symbols: [ "C6orf95" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ZC3H12D gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 36 | 41 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 36 | 6 | 1 |
Variants in ZC3H12D
This is a list of pathogenic ClinVar variants found in the ZC3H12D region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
6-149450688-G-T | not specified | Uncertain significance (May 20, 2024) | ||
6-149450708-G-T | not specified | Uncertain significance (Oct 10, 2023) | ||
6-149450709-C-T | not specified | Uncertain significance (Oct 10, 2023) | ||
6-149450762-G-A | not specified | Uncertain significance (Dec 22, 2023) | ||
6-149450773-C-T | not specified | Uncertain significance (May 13, 2024) | ||
6-149450795-C-G | not specified | Likely benign (Jan 23, 2023) | ||
6-149450806-G-T | not specified | Uncertain significance (Sep 01, 2021) | ||
6-149450874-G-A | not specified | Uncertain significance (Jul 12, 2022) | ||
6-149450900-G-A | not specified | Uncertain significance (May 31, 2023) | ||
6-149450902-C-T | Likely benign (Jul 17, 2018) | |||
6-149450914-G-C | Likely benign (Dec 01, 2022) | |||
6-149450965-G-C | not specified | Uncertain significance (Dec 06, 2023) | ||
6-149450969-G-A | not specified | Uncertain significance (Apr 25, 2022) | ||
6-149450998-G-C | not specified | Likely benign (Jan 19, 2022) | ||
6-149451016-G-T | not specified | Uncertain significance (Jul 12, 2023) | ||
6-149451027-G-C | not specified | Uncertain significance (Oct 20, 2023) | ||
6-149451087-G-T | not specified | Uncertain significance (Oct 20, 2021) | ||
6-149451133-C-A | not specified | Uncertain significance (Feb 28, 2024) | ||
6-149451138-C-G | not specified | Uncertain significance (Aug 10, 2021) | ||
6-149451152-C-A | not specified | Uncertain significance (Feb 05, 2024) | ||
6-149451205-G-C | not specified | Uncertain significance (Oct 22, 2021) | ||
6-149451228-A-T | not specified | Uncertain significance (Jul 25, 2023) | ||
6-149451327-C-A | not specified | Uncertain significance (Mar 20, 2023) | ||
6-149452669-A-T | not specified | Uncertain significance (Sep 20, 2023) | ||
6-149452693-C-T | not specified | Uncertain significance (Feb 15, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ZC3H12D | protein_coding | protein_coding | ENST00000409806 | 5 | 37404 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.156 | 0.830 | 124633 | 0 | 9 | 124642 | 0.0000361 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.40 | 203 | 268 | 0.759 | 0.0000167 | 3316 |
Missense in Polyphen | 57 | 101.44 | 0.56193 | 1115 | ||
Synonymous | 2.75 | 83 | 122 | 0.683 | 0.00000824 | 1144 |
Loss of Function | 2.11 | 3 | 10.3 | 0.291 | 5.10e-7 | 118 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000155 | 0.000152 |
Ashkenazi Jewish | 0.0000994 | 0.0000994 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000269 | 0.0000265 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000328 | 0.0000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: May regulate cell growth likely by suppressing RB1 phosphorylation (PubMed:19531561). May function as RNase and regulate the levels of target RNA species (Potential). In association with ZC3H12A enhances the degradation of interleukin IL-6 mRNA level in activated macrophages (PubMed:26134560). Serve as a tumor suppressor in certain leukemia cells (PubMed:17210687). Overexpression inhibits the G1 to S phase progression through suppression of RB1 phosphorylation (PubMed:19531561). {ECO:0000269|PubMed:17210687, ECO:0000269|PubMed:19531561, ECO:0000269|PubMed:26134560, ECO:0000305}.;
- Disease
- DISEASE: Note=A chromosomal aberration involving ZC3H12D may be the cause of the transformation of follicular lymphoma (FL) to diffuse large B-cell lymphoma (DLBCL). Translocation t(2;6)(p12;q25) with IGK. Resulting protein may not be expressed.;
Recessive Scores
- pRec
- 0.107
Haploinsufficiency Scores
- pHI
- 0.0520
- hipred
- Y
- hipred_score
- 0.516
- ghis
- 0.426
Essentials
- essential_gene_CRISPR
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.384
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | High |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Zc3h12d
- Phenotype
- hematopoietic system phenotype; immune system phenotype;
Gene ontology
- Biological process
- 3'-UTR-mediated mRNA destabilization;nucleic acid phosphodiester bond hydrolysis
- Cellular component
- P-body;nucleoplasm;cytoplasmic ribonucleoprotein granule
- Molecular function
- endonuclease activity;protein binding;metal ion binding